BCAL Diagnostics Limited (AU:BDX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BCAL Diagnostics Limited (BDX) has stated in response to the ASX Compliance Price Query that there is no undisclosed information that could explain recent trading activity in its securities. The company is currently in the process of a capital raise through share placement, pending board approval and finalization. BDX also observed an unrelated surge in shares of CLEO Diagnostics, which might have influenced BDX’s share activity, though this remains speculative.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.